Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2007 1
2009 2
2010 5
2011 5
2012 6
2013 12
2014 13
2015 15
2016 20
2017 16
2018 14
2019 10
2020 10
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 26288712

109 results
Results by year
Filters applied: . Clear all
Page 1
Advances and challenges in the management of complement-mediated thrombotic microangiopathies.
Davin JC, van de Kar NC. Davin JC, et al. Ther Adv Hematol. 2015 Aug;6(4):171-85. doi: 10.1177/2040620715577613. Ther Adv Hematol. 2015. PMID: 26288712 Free PMC article. Review.
Genetic Atypical Hemolytic-Uremic Syndrome.
Noris M, Bresin E, Mele C, Remuzzi G. Noris M, et al. 2007 Nov 16 [updated 2016 Jun 9]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 20301541 Free Books & Documents. Review.
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S. Campistol JM, et al. Nefrologia. 2015;35(5):421-47. doi: 10.1016/j.nefro.2015.07.005. Epub 2015 Oct 9. Nefrologia. 2015. PMID: 26456110 Free article. English, Spanish.
Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
Okumi M, Tanabe K. Okumi M, et al. Nephrology (Carlton). 2016 Jul;21 Suppl 1:9-13. doi: 10.1111/nep.12776. Nephrology (Carlton). 2016. PMID: 26988663 Review.
Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future.
Risitano AM, Marotta S. Risitano AM, et al. Semin Immunol. 2016 Jun;28(3):223-40. doi: 10.1016/j.smim.2016.05.001. Epub 2016 Jun 23. Semin Immunol. 2016. PMID: 27346521 Review.
[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C. Frémeaux-Bacchi V, et al. Rev Med Interne. 2011 Apr;32(4):232-40. doi: 10.1016/j.revmed.2009.09.039. Epub 2011 Mar 3. Rev Med Interne. 2011. PMID: 21376430 French.
An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
Sengul Samanci N, Ayer M, Ergen A, Ozturk S. Sengul Samanci N, et al. Transfus Apher Sci. 2015 Jun;52(3):314-6. doi: 10.1016/j.transci.2015.01.006. Epub 2015 Jan 12. Transfus Apher Sci. 2015. PMID: 25634788
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S. Weitz M, et al. Pediatr Nephrol. 2011 Aug;26(8):1325-9. doi: 10.1007/s00467-011-1879-9. Epub 2011 May 10. Pediatr Nephrol. 2011. PMID: 21556717
Atypical hemolytic uremic syndrome.
Loirat C, Frémeaux-Bacchi V. Loirat C, et al. Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Orphanet J Rare Dis. 2011. PMID: 21902819 Free PMC article. Review.
Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
Ueda Y, Miwa T, Ito D, Kim H, Sato S, Gullipalli D, Zhou L, Golla M, Song D, Dunaief JL, Palmer MB, Song WC. Ueda Y, et al. Kidney Int. 2019 Jul;96(1):67-79. doi: 10.1016/j.kint.2019.01.009. Epub 2019 Feb 27. Kidney Int. 2019. PMID: 30910380
109 results
Jump to page
Feedback